Cardiology and Angiology: An International Journal

The management of acute coronary syndromes (ACS) has evolved considerably since the introduction of transluminal coronary angioplasty (PTCA) in 1977. This study analyzes acute coronary syndromes hospitalized in the cardiology department and who benefited from angioplasty as well as their outcome. This is a descriptive retrospective study, conducted over a three-year period from January 1, 2012 to December 1, 2014, with a total of 250 patients. In this study, angiographic success was obtained in the majority of cases, with satisfactory restoration of coronary flow. However, some per-procedural complications, such as rhythm disturbances (2.8%) and thromboembolic complications (1.4%), were observed. This study also revealed that 5% of patients experienced a recurrence of infarction within the first six months. Long-term results of primary angioplasty show improved survival and reduced hospitalizations for heart failure. Technological advances, including the use of drug-eluting stents, have significantly improved short-, medium-, and long-term outcomes, reducing complications such as restenosis and increasing overall survival. Patient education on secondary prevention measures, including appropriate lifestyle and regular monitoring, is crucial to reduce recurrences and improve patients’ quality of life in the long term.